Routine insider filing with no trading activity. Monitor future Form 4 filings for any open-market purchases or sales by the CEO, which would provide more actionable signals.
Price Chart
Executive Summary
Andrew C. Orth filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing his position as President & CEO of City Therapeutics, Inc. (CTY). The filing reports 1,063,154 shares of common stock directly owned, along with options to purchase 285,558 shares at $0.92 and 301,358 shares at $5.36. This is a routine insider filing required upon becoming an officer, with no material new information for traders.
Key Facts
- Andrew C. Orth is President & CEO of City Therapeutics, Inc.
- Directly owns 1,063,154 shares of common stock.
- Holds options to buy 285,558 shares at $0.92 (expiring 2034-12-10) and 301,358 shares at $5.36 (expiring 2036-06-02).
- Filing is a standard Form 3 initial ownership report, not a transaction.
Financial Impact
No financial impact; this is a disclosure of existing holdings, not a transaction.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-116353 |
| Document: 0001104659-26-116353-index-headers.html | 0001104659-26-116353 |
| Document: 0001104659-26-116353-index.html | 0001104659-26-116353 |
| Document: 0001104659-26-116353.txt | 0001104659-26-116353 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13D | $20.79 | awaiting T+1 | — | $21.26 (+2.26%) |
Oct 26, 2026 today | SC 13G | $20.79 | awaiting T+1 | — | $21.26 (+2.26%) |
Oct 22, 2026 4d ago | SC 13G | $20.77 $20.77 | · 0.00% | ▲ +0.52% | $21.26 (+2.36%) |
Oct 19, 2026 7d ago | Insider Cluster | $20.83 $20.43 | ▼ −1.92% | ▼ −2.45% | $21.26 (+2.06%) |
Oct 19, 2026 7d ago | Press Release | $20.83 $20.43 | ▼ −1.92% | ▼ −2.45% | $21.26 (+2.06%) |
Oct 16, 2026 10d ago | 424B4 | $21.46 $20.83 | ▼ −2.94% | ▼ −3.27% | $21.26 (−0.93%) |
Oct 16, 2026 11d ago | EFFECT | $22.40 $21.46 | ▼ −4.20% | ▼ −4.62% | $21.26 (−5.09%) |
Oct 15, 2026 11d ago | 3 | $22.40 $21.46 | ▼ −4.20% | ▼ −4.62% | $21.26 (−5.09%) |
Oct 15, 2026 11d ago | 3 | $22.40 $21.46 | ▼ −4.20% | ▼ −4.62% | $21.26 (−5.09%) |
Oct 15, 2026 11d ago | 3 | $22.40 $21.46 | ▼ −4.20% | ▼ −4.62% | $21.26 (−5.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers